|
Name |
Dihydroalterperylenol
|
Molecular Formula | C20H16O6 | |
IUPAC Name* |
1,4,9,12b-tetrahydroxy-2,11,12,12a-tetrahydro-1H-perylene-3,10-dione
|
|
SMILES |
C1CC(=O)C2=C(C=CC3=C2C1C4(C(CC(=O)C5=C(C=CC3=C54)O)O)O)O
|
|
InChI |
InChI=1S/C20H16O6/c21-11-4-1-8-9-2-5-13(23)18-14(24)7-15(25)20(26,19(9)18)10-3-6-12(22)17(11)16(8)10/h1-2,4-5,10,15,21,23,25-26H,3,6-7H2
|
|
InChIKey |
IBJQWUOEZZLWJA-UHFFFAOYSA-N
|
|
Synonyms |
Dihydroalterperylenol
|
|
CAS | NA | |
PubChem CID | 14213483 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 352.3 | ALogp: | 1.4 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 26 | QED Weighted: | 0.579 |
Caco-2 Permeability: | -5.45 | MDCK Permeability: | 0.00000798 |
Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.02 |
Human Intestinal Absorption (HIA): | 0.901 | 20% Bioavailability (F20%): | 0.983 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.129 | Plasma Protein Binding (PPB): | 92.59% |
Volume Distribution (VD): | 1.031 | Fu: | 7.20% |
CYP1A2-inhibitor: | 0.318 | CYP1A2-substrate: | 0.102 |
CYP2C19-inhibitor: | 0.102 | CYP2C19-substrate: | 0.057 |
CYP2C9-inhibitor: | 0.448 | CYP2C9-substrate: | 0.675 |
CYP2D6-inhibitor: | 0.477 | CYP2D6-substrate: | 0.255 |
CYP3A4-inhibitor: | 0.386 | CYP3A4-substrate: | 0.177 |
Clearance (CL): | 4.498 | Half-life (T1/2): | 0.068 |
hERG Blockers: | 0.047 | Human Hepatotoxicity (H-HT): | 0.138 |
Drug-inuced Liver Injury (DILI): | 0.769 | AMES Toxicity: | 0.853 |
Rat Oral Acute Toxicity: | 0.559 | Maximum Recommended Daily Dose: | 0.93 |
Skin Sensitization: | 0.364 | Carcinogencity: | 0.456 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.132 |
Respiratory Toxicity: | 0.508 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003252 | 0.738 | D0H6QU | 0.303 | ||||
ENC005311 | 0.738 | D01XDL | 0.298 | ||||
ENC003652 | 0.738 | D0R9WP | 0.289 | ||||
ENC000835 | 0.714 | D0R3JB | 0.286 | ||||
ENC005389 | 0.714 | D0R6RC | 0.285 | ||||
ENC000881 | 0.600 | D08LTU | 0.282 | ||||
ENC000841 | 0.576 | D07MGA | 0.279 | ||||
ENC002360 | 0.543 | D0H1AR | 0.279 | ||||
ENC003841 | 0.526 | D07JHH | 0.274 | ||||
ENC003960 | 0.495 | D02GAC | 0.271 |